Cardiovascular risk factors in climacteric women with hyperuricemia
Abstract
Aim. To study risk factors (RF) of cardiovascular disease (CVD) in climacteric women with hyperuricemia.
Material and methods. This cross-sectional study included 672 women, divided into quartiles (n=168 each) by uric acid (UA) levels. Patients from 1st and 4th quartiles were compared. Anthropometry, lipid and carbohydrate metabolism parameters were assessed, arterial hypertension (AH), coronary heart disease, and chronic heart failure were diagnosed. Stroke, transient ischemic attack, and myocardial infarction in anamnesis were also registered.
Results. Hyperuricemia was observed in 190 women. In 4th quartile, obesity and overweight prevalence was significantly higher than in 1st quartile: 62 (36,9%), 69 (41,1%) and 43 (25,6%), 63 (37,5%), respectively. More than 50% of the 4th quartile patients had waist circumference >88 cm. In hyperuremic women, hypertriglyceridemia, low levels of high-density lipoprotein cholesterol (HDL-CH), plus increased levels of very low-density lipoprotein cholesterol (VLDL-CH) and atherogenicity index (AI) were significantly more prevalent.
Conclusion. In climacteric women with hyperuricemia, abdominal obesity and hypertriglyceridemia prevalence, VLDL-CH and AI levels are increased, and HDL-CH levels are decreased.
About the Authors
N. V. Tagiltseva
Ural State Medical Academy, State Federal Agency for Health and Social Development, Yekaterinburg
Russian Federation
Russian Federation
N. V. Izmozherova
Ural State Medical Academy, State Federal Agency for Health and Social Development, Yekaterinburg
Russian Federation
Russian Federation
A. A. Popov
Ural State Medical Academy, State Federal Agency for Health and Social Development, Yekaterinburg
Russian Federation
Russian Federation
A. N. Andreev
Ural State Medical Academy, State Federal Agency for Health and Social Development, Yekaterinburg
Russian Federation
Russian Federation
References
1. Джанашия П.Х., Диденко В.А. Является ли гиперурекимия компонентом метаболического синдрома? РКЖ 2001; 1(27): 29-34.
2. Донсков А.С., Балкаров И.М., Голубь Г.В. и др. Клиническое значение индекса массы тела и индекса талия бедро у пациентов с артериальной гипертензией: связь с повышением мочевой кислоты. Клин мед 2002; 1: 31-4.
3. Кобалава Ж.Д., Толкачева В.В, Караулова Ю.Л. Мочевая кислота – маркер и/или новый фактор риска развития сердечно-сосудистых осложнений. РМЖ 2002; 10(10): 431-6.
4. Сметник В.П., Ткаченко Н.М., Глезер Г.А., Москаленко Н.П. Климактерический синдром. Москва «Медицина» 1988; 288 с.
5. Соловьева А.О., Балкаров М.И., Сметник В.П. и др. Особенности обмена мочевой кислоты у женщин в климактерии. Клин мед 2005; 83(5): 42-5.
6. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension 1999; 34: 144-50.
7. Alderman MH. Serum Uric Acid As a Cardiovascular Risk Factor for Heart Disease. Current Hypertension Reports 2001; 3: 184-9.
8. Chang HY, Pan WH, Yeh WT, Tasi KS. Hyperuricaemia and gout in Taiwn: results from the Nutritional and Health Survey in Taiwan (1993-1996). J Rheumatol 2001; 28(7): 1640-6.
9. Chiou WK, Lin JD, Weng HF, еt al. Correlation of the dysmetabolic risk factors with different anthropometric measurements. Endocr J 2005; 52(1): 139-48.
10. Conen D, Wietlisbach V, Bovet P, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC. Public Health 2004; 4: 9- 17.
11. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7-13.
12. Fang J, Alderman MN. Serum uric acid and cardiovascular mortality – The NHANES 1 Epidemiologic Follow–up Study, 1971–1992. JAMA 2000; 283: 2404-10.
13. Goya Wannamethee S. Serum Uric Acid Is Not an Independent Risk Factor for Coronary Heart Disease. Cur Hypertens Reports 2001; 3: 190-6.
14. Heller HJ, Sakhaee K, Moe OW, Pak CY. Etiological role of estrogen status in renal stone formation. J Urol (Baltimore) 2002; 168(5): 1923-7.
15. Kerkalainen P, Sarlund H, Laakso M. Long–term association of cardiovascular risk factors with impaired insulin secretion and insulin resistance. Metabolism 2000; 49: 1247-54.
16. Lai S.W., Tan C.K., Ng K.C. Epidemiology of hyperuricaemia in the elderly. Yale J Biol Med 2001; 74(3): 151-7.
17. Lin KC, Lin HY, Chou P. Community based eidemiological study on hyperuricaemia and gout in Kin-hu, Kinmen. J Reumatol 2000; 27(4): 1045-50.
18. Meyers AR, Epstein FH, Dodge HJ, et al. Hyperuricaemia of serum uric acid to risk factors in coronary artery disease. Am J Med 1966; 45: 520-8.
19. Nagahama K, Inoue T, Iseki K, et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Ok. Hypertens Res 2004; 27(11): 835-41.
20. Sumino H, Ichikawa S, Kanda T, et al. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 1999; 354(2): 1643-4.
21. Verdecchia P, Schillaci G, Reboldi G, et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: the Piuma Study. Hypertension 2000; 36: 1072-8.
22. Yamamoto T. Influence of sex and age on serum uric acid level. Nippon Rincho 2003; 61(Suppl. 1): 131-3.
23. Yoo TW, Sung KC, Shin HS, et al. Relationship between serum uric acid concentration and insulin resistance and metabolic syndrome. Circ J 2005; 69(8): 928-33.
Review
For citations:
Tagiltseva N.V., Izmozherova N.V., Popov A.A., Andreev A.N. Cardiovascular risk factors in climacteric women with hyperuricemia. Cardiovascular Therapy and Prevention. 2007;6(4):67-71. (In Russ.)
Views:
590
Email this article 
